MAPT and Alzheimer disease: Elevated MG concentrations have been reported in both diabetic and AD patients [21,22], and experimental MG administration induces tau hyperphosphorylation, Aβ accumulation, and memory deficits in wild-type rodents, supporting its validity as a non-transgenic Alzheimer-like model [23,24].